Partial list of confirmed speakers.
NEXT GENERATION RNA BASED THERAPEUTICS
THE FUTURE OF PD THERAPY; WHY MULTI TARGET DRUGS
Moussa Youdim (Israel)
CSF AND BLOOD BIOMARKERS FOR AD – PATHOPHYSIOLOGY, DIAGNOSTIC ALGORITHMS AND THERAPY MONITORING
Kaj Blennow (Sweden)
TRANSLATIONAL NEUROPATHOLOGY: BEGINNING AT THE END TO INFORM THE BEGINNING
Melissa Murray (USA)
CONSIDERATION OF BLOOD-BASED BIOMARKERS FOR COMMUNITY SCREENING – INFLUENCE OF COMORBIDITIES, RACE/ETHNICITY, AND SEX
Michelle Mielke (USA)
DISEASE MODIFIERS FOR ALZHEIMER’S DISEASE – A REGULATORY PERSPECTIVE
Yaning Wang (USA)
THE FIRST DISEASE-MODIFYING TREATMENTS FOR AD: A GLASS HALF FULL
Denis Selkoe (USA)
